Target intelligence / Profile preview

Catenin beta-1 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Catenin beta-1 pseudogene is a processed pseudogene similar in sequence to the *CTNNB1* gene, which normally encodes the important cell signaling and adhesion protein beta-catenin. Unlike the functional gene, this pseudogene does not code for a functional protein product and is not involved in canonical pathways such as the Wnt/beta-catenin pathway. Pseudogenes like this are considered nonfunctional segments of DNA and are usually not transcribed or translated into active proteins. Their primary significance is in genomic studies where they might be confused with functional genes, but they are generally not relevant as therapeutic targets, biomarkers, or drug targets[2][5].\n\nEssential clarifications:\n- This entry is not a protein-coding gene nor a validated drug target.\n- Pseudogenes like this are usually classified as "junk DNA" with no known therapeutic, diagnostic, or mechanistic relevance in disease or pharmacology[5].\n- Information regarding molecular function, pathways, disease roles, and pharmaceutical relevance should be attributed to the functional *CTNNB1* gene or beta-catenin protein, **not** to the pseudogene itself[1][4][5].

Other names
catenin, beta 1, 88kDa pseudogeneLOC100422013ENSG00000278824

Beyond the preview

Go deeper on Catenin beta-1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catenin beta-1 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call